Corvus Pharmaceuticals (CRVS) PT Raised to $13 at Mizuho
Tweet
Share
E-mailGet Alerts CRVS Hot Sheet
Price: $14.89 -1.65%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Mizuho analyst Graig Suvannavejh raised the price target on Corvus Pharmaceuticals (NASDAQ: CRVS) to $13.00 (from $11.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
